Pseudotype viruses bearing envelope antigens of Japanese isolates of human T-cell leukemia viruses type I. NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Pseudotype viruses bearing envelope antigens of Japanese isolates of human T-cell leukemia viruses type I.

Princess Takamatsu Symp. 1984;15:159-64. Unique Identifier : AIDSLINE MED/86111557
Hoshino H; Weiss RA; Clapham P; Miwa M; Miyoshi I; Yoshida M; Sugimura T

Abstract: We tried to transmit human T-cell leukemia virus type I (HTLV-I) into non-lymphoid cells and found that S+L- CCC cat cells were permissive for HTLV-I. Using these HTLV-positive cat cells, vesicular stomatitis virus (VSV) pseudotypes bearing envelope antigens of Japanese isolates of HTLVs were prepared and their reactivities with human or rabbit serum were examined. Japanese HTLV2M, HTLV10Y, and HTLVMT-2 pseudotypes and American HTLVPL pseudotype were neutralized by sera of Japanese and American patients with adult T-cell leukemia/lymphoma (ATL) and rabbit antisera against HTLV. Each serum showed similar antibody titers against different pseudotypes. Thus, envelope antigens of four HTLVs that reacted with the human and rabbit sera were considered to belong to a single serotype.
Keywords: Animal Antibodies, Viral/ANALYSIS Antigens, Viral/*ANALYSIS Cats Genes, Viral Human HTLV-BLV Viruses/GENETICS/*IMMUNOLOGY Japan Leukemia/IMMUNOLOGY/MICROBIOLOGY Rabbits Vesicular Stomatitis-Indiana Virus/IMMUNOLOGY Viral Envelope Proteins/IMMUNOLOGY JOURNAL ARTICLE

KWDanimalantibodies,viral/analysisantigens,viral/KWDanalysiscatsgenes,viralhumanhtlv-blvviruses/genetics/KWDimmunologyjapanleukemia/immunology/microbiologyrabbitsvesicularstomatitis-indianavirus/immunologyviralenvelopeproteins/immunologyjournalarticle
860530
M8650214

Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .